Today, we presented an update to our Balanced Adherence Metric at the PQA Annual Meeting & Innovation Forum in Arlington, VA.Objectively evaluating adherence is difficult. Beyond checking blood levels of
The Balanced Adherence Metric (BAM): a new spin on current methods for calculating adherence with pharmacy claims data. Bill Simpson, B.Sc, Ph.D (1,2) and Amos Adler, M.Sc. (2)
Although I don’t know him personally, Joseph Kvedar is someone who I look up to. He’s been at the forefront of digital health for many years and a leader in
Digital health is turning into one of those catch-all terms that people use to describe everything from electronic medical records to smartphone apps to wearable devices. While I’m happy that
Posted on March 15, 2016 by Mary Camp Another HIMSS conference makes it three in a row for me. I feel like a veteran and enjoyed sharing my inside tips for rookies:
Posted on February 12, 2015
On February 11, 2014, MEMOTEXT was one of the 5 MaRS based mHealth/digital health start-ups, invited to speak at the University of Toronto’s Rotman School of Management’s IT in Healthcare Speaker Series: Start-Ups. MEMOTEXT Founder and President Amos Adler spoke about how MEMOTEXT’s mhealth/digital health communication platform cuts costs for all stakeholders in the healthcare system and delivers clinically proven increases to adherence.
Posted on February 14, 2016 by Amos Adler Being a digital health entrepreneur is an educational experience to say the least. Most lessons are about pain, endurance and learning how to persevere.
TORONTO, Feb. 4, 2016 /CNW/ – A 2014 pilot program for patients with chronic diseases by Green Shield Canada (GSC) and MEMOTEXT Corp. has revealed some new facts about
Posted on January 24, 2016 by Noah Nemoy Advancing the way people interact with their health technology is a pillar of MEMOTEXT’s mission. The greatest part about working on so many different programs for
Posted on January 24, 2016 by Noah Nemoy As a valued MEMOTEXT client we’d like to give you a sneak peek at our latest technological advancement: SAM! SAM is the MEMOTEXT ChatBot for
Looking back on MEMOTEXT’s accomplishments this fall
Posted on December 2, 2015 by Noah Nemoy
This autumn has been an exciting time for MEMOTEXT. In September our Founder and President Amos Adler had the opportunity to be a main stage speaker at Stanford Medicine X 2015. Presenting the abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” Amos rocked the crowd explaining the MEMOTEXT methodology. He had a fantastic time at the event and the “Cat pics + health data = behavior change” line got a substantial amount of press coverage.
Posted on November 20, 2015 by Amos Adler
Using digital engagement to increase medication adherence is our novel solution to a complex problem. With non-adherence caused by multiple factors unique to each individual patient, a-one-size-fits-all-solution can’t work and won’t work. Instead, at MEMOTEXT we personalize each patient’s support program. By encouraging patient input, adapting to changes in mood and lifestyle, we can develop a medication adherence and support program that works best.
We use cookies to ensure you get the best experience on our website. By continuing to browse this website, you accept the use of the cookies for the stated purpose. Learn more by reading our privacy policy.
Get updates on new products, projects and stay on top of all things MEMOTEXT.